AN OPEN-LABEL TRIAL ASSESSING THE OPTIMAL DOSE EFFICACY AND SAFETY OF GBM-5 IN THE TREATMENT OF PAIN ASSOCIATED WITH COMPLEX REGIONAL PAIN SYNDROME
- Registry ID
- MEDNC-001
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Study type
- INTERVENTIONAL
- Sponsor
- GILBERT BLAISE INC
- Last update
- 2019-10-16
Conditions
- COMPLEX REGIONAL PAIN SYNDROME (CRPS)
Related clinical trials
View on source registry